Repeated infliximab therapy after serum sickness-like reaction in Crohn's disease

Journal of Emergency Medicine

Volumn 32, Issue 2, 2007, Pages 209-210

  Miheller, Pál ^a   Muzes, Györgyi ^a   Lakatos, Gábor ^a   Mihály, Emese ^a   Tulassay, Zsolt ^a,b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; INFLIXIMAB; METHYLPREDNISOLONE;

ARTHRALGIA; CLINICAL FEATURE; CONTINUOUS INFUSION; CROHN DISEASE; DELAYED HYPERSENSITIVITY; DRUG DOSE REDUCTION; DRUG FEVER; HUMAN; ILEOANAL ANASTOMOSIS; LETTER; MALAISE; MULTIPLE CYCLE TREATMENT; MYALGIA; PRIORITY JOURNAL; RECTOVAGINAL FISTULA; RECURRENT DISEASE; RELAPSE; REPEATED DRUG DOSE; SERUM SICKNESS; SHORT COURSE THERAPY; SKIN DEFECT; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; ULCERATIVE COLITIS;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; CROHN DISEASE; HUMANS; HYPERSENSITIVITY, DELAYED; MALE; SERUM SICKNESS;

EID: 33847256485     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jemermed.2006.12.005     Document Type: Letter

References (3)

1. Cheifetz A., Smedley M., Martin S., et al. The incidence and management of infusion reactions to infliximab: a large center experience. Am J Gastroenterol 98 (2003) 1315-1324
2. Gamarra R.M., McGraw S.D., Drelichman V.S., and Maas L.C. Sserum sickness-like reactions in patients receiving intravenous infliximab. J Emerg Med 30 (2006) 41-44
3. Kugathasan S., Levy M.B., Saeian K., et al. Infliximab retreatment in adults and children with Crohn's disease: risk factors for the development of delayed severe systemic reaction. Am J Gastroenterol 97 (2002) 1408-1414